Survival and prognostic implications for radical retropubic prostatectomy for patients with microscopic bladder neck involvement
Saturday, October 31st, 2009 Posted in prostatectomy | No Comments »A recent study at University of Florence, Florence, Italy, aimed to report the oncological outcome of 106 patients who had locally advanced prostate cancer with microscopic bladder neck invasion, identified in a series of 1129 patients surgically treated with retropubic ...
Physical activity and prostate cancer risk
Friday, October 30th, 2009 Posted in prostate cancer risks | No Comments »A new study by an international team of researchers has further endorsed the value of regular exercise and activity in the long-term prevention of prostate cancer. Researchers concluded that prostate cancer risk was inversely related to total levels of lifetime ...
Impact of socioeconomic status on prostate cancer presentation, treatment
Thursday, October 29th, 2009 Posted in prostate cancer, prostate cancer risks | No Comments »A recent study of the impact of socioeconomic status on prostate cancer presentation, treatment, and prognosis in Geneva, Switzerland, evaluated the impact of socioeconomic status on prostate cancer diagnosis, management, and outcomes over time. Researchers emphasize the impact of low socioeconomic status on ...
Effect of prostate cancer on serum testosterone levels
Tuesday, October 27th, 2009 Posted in prostate cancer risks | No Comments »Androgens are essential for prostatic growth and development, but also play a significant role in the pathogenesis of prostate disease. According to a new study at Chiba University, Japan, the traditional view that higher testosterone levels represent a risk factor ...
New strategies in treatment of metastatic prostate cancer
Monday, October 26th, 2009 Posted in prostate cancer | No Comments »Provenge has been shown to improve the survival of men with castrate resistant prostate cancer (CRPC). Growth factors are potential targets for treating prostate cancer. Unfortunately, agents targeting these factors have been ineffective. Monoclonal antibodies to block IL-6 have been ...
Robotic prostate cancer surgery is leaving men with more impotence
Sunday, October 25th, 2009 Posted in prostatectomy | No Comments »Scientists have raised doubts against the efficacy of robotic prostate cancer surgery, claiming that instead of being a saviour, the procedure is leaving men with more incontinence and impotence than traditional techniques. In the paper, the researchers compared the long-term results ...
Comparative effectiveness of minimally invasive vs open radical prostatectomy
Sunday, October 25th, 2009 Posted in prostatectomy | No Comments »Minimally invasive radical prostatectomy (MIRP) has diffused rapidly despite limited data on outcomes and greater costs compared with open retropubic radical prostatectomy (RRP). A study at Brigham and Women's Hospital, Boston, USA has investigated the effectiveness of MIRP vs RRP. The ...
About the validity of PSA as a screening test
Friday, October 23rd, 2009 Posted in prostate cancer diagnosis | No Comments »A Swedish research at Gävle Hospital, has attempted to evaluate whether the PSA test actually attains standards of sufficient validity for use as a prostate cancer screening tool. Dr Holmström, the study leader, and his coleagues concluded, based on recent screening ...
Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails
Thursday, October 22nd, 2009 Posted in watchful waiting | No Comments »Acording to a study at The Johns Hopkins Hospital, most progression after active surveillance occurs 1 to 2 years after diagnosis suggesting undersampling of more aggressive tumor rather than progression of indolent tumor. Even with progression most tumors have favorable ...
the American Cancer Society to make major revision in cancer screening guidance
Wednesday, October 21st, 2009 Posted in prostate cancer | No Comments »According to an article by Gina Kolata in the New York Times today, the American Cancer Society is working on a major revision of its guidelines on cancer screening — not just for prostate cancer but for many forms of ...